Particulate matter (PM2.5) as a potential SARS-CoV-2 carrier

Norefrina Shafinaz Md Nor1, Chee Wai Yip1, Nazlina Ibrahim2

  • 1Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia UKM, 43600, Bangi, Selangor, Malaysia.

Scientific Reports
|January 29, 2021
PubMed

Insights

Fine indoor air particulates, known as PM2.5, can transport the SARS-CoV-2 virus. Higher virus levels were found in more crowded hospital wards, suggesting a link to room design and patient factors.

Area of Science:

  • Environmental Science
  • Infectious Disease Epidemiology
  • Aerosol Science

Background:

  • The COVID-19 pandemic highlighted the need to understand SARS-CoV-2 transmission routes.
  • While respiratory droplets were initially considered the primary mode, indirect transmission via fomites and aerosols became a concern.
  • The role of specific airborne particles in virus transport required further investigation.

Purpose of the Study:

  • To investigate the potential of fine indoor air particulates (PM2.5) as a transport medium for SARS-CoV-2.
  • To determine the correlation between SARS-CoV-2 RNA on PM2.5 and hospital ward characteristics.
  • To explore the influence of patient factors on airborne virus concentration.

Main Methods:

  • Collection of PM2.5 samples over four weeks in four hospital wards with varying COVID-19 patient clusters.
  • Utilized 48-hour measurement intervals for comprehensive air particulate analysis.
  • Quantified SARS-CoV-2 RNA presence on collected PM2.5 samples.

Main Results:

  • SARS-CoV-2 RNA was detected on indoor air PM2.5 samples.
  • The highest concentrations of virus-laden PM2.5 were observed in wards with a greater number of occupants.
  • A correlation was suggested between virus-laden PM2.5 and hospital ward design.

Conclusions:

  • Fine indoor air particulates (PM2.5) can act as a transport agent for SARS-CoV-2.
  • Hospital ward occupancy and design appear to influence airborne SARS-CoV-2 RNA levels on PM2.5.
  • Patient symptoms and numbers are significant factors affecting airborne virus concentration in enclosed spaces.